Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ANDA Approvals, Complete Responses Hit Record In FY 2016

Oct 12 2016

• By Derrick Gingery

StacksOfPapers_1200x675

Related Content

ANDA Reviews: First-Cycle Desired, But Two-Cycles OK?

Jul 27 2015

EpiPen Generics: Woodcock Explains Injector Studies

Sep 22 2016

ANDA User Fees Offer Sponsor Relief, But More Facility Pain

Jul 26 2016

GDUFA Performance Goals For Fiscal Years 2013-2017

Dec 12 2011

ANDA Approvals, Submissions Decline With New Review Goal Coming

Aug 12 2016

FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs

Sep 27 2016

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

Additional Topics

United States Drug Review Pricing Debate Approvals Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window